Close Menu

aneuploidy

The decision invalidates 13 claims of a patent that is at the center of litigation filed by Illumina alleging infringement by Ariosa Diagnostics.

NEW YORK (GenomeWeb) – Microarray-based non-invasive prenatal testing firm CellScape has shut down.
According to its LinkedIn page, the company, which had been headquartered in Newark, Calif., ceased operations in September.

NEW YORK (GenomeWeb) – Sequenom is looking to its deal with Quest Diagnostics and a new noninvasive prenatal test, VisibiliT, which it will launch in Europe for trisomies 21 and 18, to help drive new revenue growth, company officials said this week.

NEW YORK (GenomeWeb) — Affymetrix and Ariosa Diagnostics today announced that they have signed a multi-year agreement under which Affymetrix will supply arrays and instruments for use in Ariosa's Harmony non-invasive prenatal test.

NEW YORK (GenomeWeb) – BGI Dx, a subsidiary of BGI, and Italian firm Bioscience Genomics today announced they have signed a five-year framework agreement focused on non-invasive prenatal testing.

As it continues to expand its presence in the non-invasive prenatal testing market, Natera has been developing its technology for the cancer diagnostics space and is poised to make announcements in that area "very soon."

NEW YORK (GenomeWeb) – Sequenom has purchased intellectual property from Isis Innovations covering noninvasive prenatal testing for nearly $14.6 million, the company said today.

NEW YORK (GenomeWeb) – A US Patent and Trademark Office board has declared that certain claims on a patent held by Sequenom are unpatentable, while it upheld other claims on the patent, US Patent No. 6,258,540.

NEW YORK (GenomeWeb) – Sengenics said this week that it has exclusively partnered with Sequenom to launch that company's VisibiliT non-invasive prenatal test in Thailand, Indonesia, and Brunei.

NEW YORK (GenomeWeb) – Laboratory Corporation of America said this week that it has developed and launched a noninvasive prenatal test for fetal chromosomal abnormalities.

Pages

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.